Initially there initially there initially there initially there initially there initially there initially there there there there there there there there there there initially there initially there initially there was no specific way to reverse the anticoagulant effect of of of of of of of of of of dabigatran in the um you know like I mean I mean um uh you you you you you you you you you you know you know event of a major bleeding event, unlike for warfarin, but a dabigatran antidote (idarucizumab) was approved by the FDA in 2015.